sucrose has been researched along with glucaric acid in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.78) | 18.7374 |
| 1990's | 9 (12.50) | 18.2507 |
| 2000's | 33 (45.83) | 29.6817 |
| 2010's | 27 (37.50) | 24.3611 |
| 2020's | 1 (1.39) | 2.80 |
| Authors | Studies |
|---|---|
| Danielson, BG; Derendorf, H; Geisser, P; Salmonson, T | 1 |
| Abbas, M; Abotalib, Z; al-Meshari, A; al-Momen, AK; al-Nuaim, L; Khashogji, T; Saddique, A | 1 |
| Akcicek, F; Atabay, G; Basci, A; Celik, A; Cirit, M; Ok, E; Ozkahya, M; Toz, H; Unsal, A | 1 |
| Bernière, J; Dehullu, JP; Gall, O; Murat, I | 1 |
| Andrade, S; Colaço, S; Oliveira, C; Ponce, P; Santos, JP; Silva, J; Ventura, H | 1 |
| Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sundin, J; Tolmachev, V; Valind, S | 2 |
| Atherton, DJ; Cox, I; Hann, I | 1 |
| Asano, T; Baxter, JG; Maebashi, N; Yamaguchi, T | 1 |
| Agbaria, Z; Baruch, R; Blum, M; Deutsch, V; Iaina, A; Irony, M; Schwartz, D; Silverberg, DS; Steinbruch, S; Yachnin, T | 1 |
| Bahner, U; Bettger, H; Kosch, M; Matzkies, F; Schaefer, RM; Teschner, M | 1 |
| Duffy, CI | 1 |
| Baruch, R; Blum, M; Iaina, A; Keren, G; Schwartz, D; Shaked, M; Sheps, D; Silverberg, DS; Steinbruch, S; Tchebiner, J; Wexler, D; Yachnin, T; Zubkov, A | 1 |
| Canziani, ME; Draibe, SA; Manfredi, SR; Neto, MC; Rangel, EB; Yumiya, ST | 1 |
| Chaimovitz, C; Mazor, D; Meyerstein, N; Tovbin, D; Vorobiov, M | 1 |
| Calişkan, S; Camsari, T; Cavdar, C; Celik, A; Onvural, B; Sifil, A; Temiz, A; Yeniçerioğlu, Y | 1 |
| Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR | 1 |
| Kosch, M; Schaefer, RM | 1 |
| Acton, RT; Barton, JC; Coghlan, ME; Ozbirn, TW; Reymann, MT | 1 |
| BUCHI, J; ZOPPI-HUG, R | 1 |
| Borisov, AV; Borisova, EV; Fesiuk, AF; Lovchinskiĭ, EV; Mordik, AI | 1 |
| Chernev, A; Chernev, T; Karag'ozova, Zh; Koleva, R | 1 |
| Anderson, J; Johnson, K; Van Wyck, D | 1 |
| Blum, M; Iaina, A; Schwartz, D; Silverberg, D; Wexler, D | 1 |
| Almer, S; Bodemar, G; Danielson, BG; Kechagias, S | 1 |
| Cuenca Espiérrez, J; García Erce, JA; Martínez Martín, AA; Modrego Aranda, FJ; Solano, VM | 1 |
| Bozhinova, S; Ivanova, I; Lukanova, M | 1 |
| Maslovsky, I | 1 |
| Bailie, GR; Clark, JA; Lane, CE; Lane, PL | 1 |
| Durandy, Y; Hulin, S | 1 |
| Ahlmén, J; Chertow, GM; Mason, PD; Vaage-Nilsen, O | 1 |
| McLoughlin, P; Musthyala, R | 1 |
| Canser, E; Gilsanz, F; Gimeno, M; Gredilla, E; Martínez, B; Pérez Ferrer, A | 1 |
| Gershanovich, ML; Livshits, ME; Makhnova, EV | 1 |
| Juncà, J | 1 |
| Huch, R; Krafft, A; Schaefer, RM | 1 |
| Binder, T; Dvorská, M; Feldmár, P; Záhumenský, J; Zmrhalová, B | 1 |
| Camsari, T; Cavdar, C; Cavdar, Z; Saglam, F; Uysal, S | 1 |
| Boyd, A; Chan, LN; Norenberg, J; Pai, AB; Raj, D | 1 |
| SLACK, HG; WILKINSON, JF | 1 |
| Backe, B; Borthen, I; Kolås, T; Løkvik, B; Nakling, J; Rognerud Jensen, OH; Salvesen, KA; Smedvig, E; Westad, S; Økland, I | 1 |
| Bailey, G; Cropper, L; Mostafa, S; Pugh-Clarke, K; Tagboto, S; Turner, J | 1 |
| Arnaout, L; Bellamy, L; Chabbouh, T; Ozier, Y; Rosencher, N | 1 |
| Chiu, DY; Fenwick, S; Kalra, PA; Kolakkat, S; Lamerton, E; Peebles, G; Sinha, S | 1 |
| Yee, J | 1 |
| Bregman, DB; Butcher, A; Goodnough, LT; Harrington, RA; Koch, TA; Morris, D; Onken, JE; Szczech, LA; Wolf, M | 1 |
| Gupta, A; Olp, J; Pai, A; Reddy, S; Zha, J; Zhuo, J | 1 |
| Brin, JF; Crommelin, DJ; Klinger, E; Mühlebach, S; Schellekens, H; Storm, G | 1 |
| Battegay, E; Breymann, C; Furrer, J; Krayenbuehl, PA; Schulthess, G | 1 |
| Dorrington, KL; León-Velarde, F; Nickol, AH; Privat, C; Rivera-Ch, M; Robbins, PA; Smith, TG; Talbot, NP | 1 |
| Bosch, MA; Bruguera, J; Cladellas, M; Comín-Colet, J; Farré, N; Gómez, M; Meroño, O; Molera, R; Segovia, A; Vila, J | 1 |
| Ávalos-Pinto, R; de la Llana-Ducrós, R; Garrido-Martín, P; Jimenez-Sosa, A; Martínez-Sanz, R; Nassar-Mansur, MI; Rodríguez Fortunez, PM; Virgos-Aller, TM | 1 |
| Chen, J; Chen, X; Cheng, M; Peng, Y; Yang, L; Yin, L | 1 |
| Bockeria, LA; Bockeria, O; Donakanian, S; Sokolskaya, M | 1 |
| Akarsu, S; Demir, H; Oguzoncul, F; Selek, S | 1 |
| Amorós-Amorós, F; Enríquez-Ascarza, R; González-Martinez, C; Millán-del Valle, I; Redondo-Pachón, MD; Sirvent-Pedreño, AE | 1 |
| Burden, R; Horgan, G; Moore, B; Pedlar, CR; Pollock, N; Whyte, GP | 1 |
| Barot, BS; Mehta, DM; Parejiya, PB; Shah, GB; Shelat, PK | 1 |
| Bentley, DP; Meek, EM | 1 |
| Akin, M; Atay, E; Erdogan, F; Karadeniz, C; Karakus, YT; Oztekin, O; Yilmaz, B | 1 |
| Cornelius, C; Goldenberg, H; Praschberger, M; Scheiber-Mojdehkar, B; Schitegg, M; Sturm, B | 1 |
| Boland, JP; Kusminsky, RE; Maxwell, D; Richmond, BK; Schlarb, CA; Todd Kuenstner, J; Willis Trammell, S; Witsberger, T | 1 |
| Hammami Ghorbel, H; Lacour, JP; Passeron, T | 1 |
| Mekic, M; Musanovic, A; Trnacevic, S | 1 |
| Cava-Sumner, B; Domínguez-Ortega, J; Kindelan-Recarte, C; Montojo-Guillén, C; Nuñez-Acevedo, B; Rodríguez-Jiménez, B | 1 |
| Baranto, A; Barreto Henriksson, H; Brantsing, C; Junevik, K; Papadimitriou, N; Thorfve, A | 1 |
| Angerosa, M; Cao, G; Toblli, JE | 1 |
| Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Servais, S; Willems, É | 1 |
| Han, ZT; Hong, M; Li, H; Zhao, YS | 1 |
| Fan, LH; Guo, Q; Li, JL; Qu, YN; Ruan, YC; Tan, TW; Yan, HJ; Yue, XZ; Zheng, WX | 1 |
| Guo, ZW; Li, N; Lou, WY; Su, HH; Wu, XL; Xu, P; Zong, MH | 1 |
| Kanao, E; Kobayashi, H; Kubo, T; Masuda, Y; Naito, T; Okada, K; Otsuka, K; Takaya, H; Tokuda, S; Yan, M | 1 |
2 review(s) available for sucrose and glucaric acid
| Article | Year |
|---|---|
[Indications and practical management of parenteral iron therapy].
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Child; Erythrocyte Count; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Male; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2003 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemodilution; Humans; Intraoperative Complications; Orthopedic Procedures; Postoperative Hemorrhage; Preoperative Care; Recombinant Proteins; Sucrose; Time Factors; Tranexamic Acid; Transfusion Reaction | 2008 |
21 trial(s) available for sucrose and glucaric acid
| Article | Year |
|---|---|
Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
Topics: Adult; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Half-Life; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Receptors, Transferrin; Spectrophotometry, Atomic; Sucrose; Transferrin | 1996 |
Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Reference Values; Sucrose; Time Factors | 1996 |
The efficiency of fractionated parenteral iron treatment in CAPD patients.
Topics: Adult; Anemia; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Organization and Administration; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Sucrose; Transferrin | 1997 |
Iron supplementation in haemodialysis--practical clinical guidelines.
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Administration Routes; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Deficiencies; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Support; Practice Guidelines as Topic; Prospective Studies; Recombinant Proteins; Renal Dialysis; Sucrose; Transferrin | 1998 |
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Sucrose | 2001 |
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
Topics: Drug Administration Schedule; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2001 |
The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Topics: Adult; Dose-Response Relationship, Drug; Erythrocyte Deformability; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Time Factors | 2003 |
[Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy].
Topics: Anemia; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemodilution; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Postoperative Complications; Reticulocyte Count; Sucrose | 2005 |
[Postpartum and early postoperative anemia after gynecological surgery: treatment with intravenous iron].
Topics: Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Humans; Injections, Intravenous; Prospective Studies; Puerperal Disorders; Sucrose | 2006 |
[Intravenous treatment of postpartum anemia with trivalent ferrum preparation].
Topics: Anemia, Iron-Deficiency; Blood Cell Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Puerperal Disorders; Sucrose | 2007 |
Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
Topics: Breath Tests; Cytochrome P-450 Enzyme System; Erythromycin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Deficiencies; Liver; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sucrose | 2007 |
A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Postpartum Period; Prospective Studies; Quality of Life; Sucrose | 2008 |
Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Administration Schedule; Drug Monitoring; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glomerular Filtration Rate; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Sucrose; Transferrin; Treatment Outcome | 2008 |
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Cardiovascular Diseases; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hemoglobins; Humans; Kidney Diseases; Male; Maltose; Middle Aged; Risk Factors; Sucrose; Treatment Outcome | 2010 |
Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration.
Topics: Adult; Double-Blind Method; Fatigue; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Patient Selection; Placebos; Premenopause; Research Design; Sucrose | 2011 |
Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial.
Topics: Acute Disease; Adult; Altitude Sickness; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Male; Oxygen; Severity of Illness Index; Sucrose; Young Adult | 2011 |
The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
Topics: Administration, Oral; Aged; Analysis of Variance; Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chi-Square Distribution; Double-Blind Method; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Spain; Sucrose; Tablets; Time Factors; Treatment Failure | 2012 |
[Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Young Adult | 2012 |
Iron deficiency anemia and levels of oxidative stress induced by treatment modality.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Antioxidants; Child; Child, Preschool; Developing Countries; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycine; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Male; Oxidative Stress; Sucrose; Turkey | 2013 |
Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Drug Resistance; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Male; Sucrose; Treatment Outcome | 2014 |
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
Topics: Anemia; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Sucrose; Survival Analysis; Transplantation, Autologous | 2015 |
49 other study(ies) available for sucrose and glucaric acid
| Article | Year |
|---|---|
[Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents].
Topics: Administration, Oral; Adolescent; Adult; Anemia; Blood Loss, Surgical; Child; Child, Preschool; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Postoperative Complications; Spinal Fusion; Sucrose | 1998 |
Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography.
Topics: Bone Marrow; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Liver; Sucrose; Tomography, Emission-Computed | 1999 |
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.
Topics: Adult; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Male; Middle Aged; Sucrose; Tomography, Emission-Computed; Transferrin | 1999 |
Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
Topics: Anemia, Iron-Deficiency; Child; Epidermolysis Bullosa Dystrophica; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Recombinant Proteins; Sucrose | 1999 |
Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats.
Topics: Administration, Oral; Adsorption; Animals; Calcium; Feces; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Phosphates; Random Allocation; Rats; Rats, Wistar; Structure-Activity Relationship; Sucrose; Time Factors | 1999 |
Iron sucrose or ferric gluconate?
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Renal Dialysis; Sucrose; Terminology as Topic | 2001 |
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Humans; Kidney Failure, Chronic; Male; Recombinant Proteins; Stroke Volume; Sucrose | 2001 |
Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment.
Topics: Adult; Bacterial Infections; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Middle Aged; Renal Dialysis; Sucrose | 2001 |
Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation.
Topics: Aged; Aged, 80 and over; Blood Proteins; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glycation End Products, Advanced; Humans; Inflammation; Infusions, Intravenous; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Renal Dialysis; Sodium Chloride; Sucrose | 2002 |
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose | 2003 |
Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy.
Topics: Aged; Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Male; Ostreidae; Renal Dialysis; Sucrose; Vibrio Infections; Vibrio vulnificus | 2003 |
[Injectable iron-oxide-sucrose].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Oxides; Sucrose | 1956 |
[Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Sucrose; Treatment Outcome | 2003 |
[Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heparin; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sucrose | 2003 |
Labile iron in parenteral iron formulations: a quantitative and comparative study.
Topics: Biological Assay; Chemistry, Pharmaceutical; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Protein Binding; Sucrose; Transferrin | 2004 |
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure.
Topics: Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Nandrolone; Nandrolone Decanoate; Sucrose | 2004 |
Treatment of anaemia in inflammatory bowel disease with iron sucrose.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Retrospective Studies; Sucrose; Treatment Outcome | 2004 |
[Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly].
Topics: Aged; Aged, 80 and over; Anemia; Blood Loss, Surgical; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Iron; Male; Sucrose | 2004 |
[How to avoid a haemotransfusion which is not lifesaving? (our experience with administration of intravenous iron to pregnant women and young mothers)].
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Drug Administration Schedule; Erythrocyte Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Sucrose | 2004 |
Intravenous iron in a primary-care clinic.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Renal Insufficiency; Sucrose | 2005 |
Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Topics: Adverse Drug Reaction Reporting Systems; Algorithms; Anaphylaxis; Drug Hypersensitivity; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Retrospective Studies; Severity of Illness Index; Sucrose; United States | 2005 |
Update on adverse drug events associated with parenteral iron.
Topics: Adverse Drug Reaction Reporting Systems; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Sucrose | 2006 |
Re: blood transfusion and orthognathic surgery a thing of the past?
Topics: Blood Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Oral Surgical Procedures; Sucrose | 2006 |
[Use of Venofer in management of anemia in cancer patients].
Topics: Adult; Aged; Anemia; Disease Progression; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sucrose; Time Factors; Treatment Outcome | 2006 |
[Ferropenic anemia: some comments].
Topics: Anemia, Iron-Deficiency; Celiac Disease; Diagnosis, Differential; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid Deficiency; Glucaric Acid; Humans; Injections, Intravenous; Iron; Sucrose | 2006 |
[Current recommendations for the treatment of iron deficiency anemia].
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Therapy, Combination; Epoetin Alfa; Erythrocyte Count; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins; Sucrose; Switzerland; Transferrin | 2007 |
Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Topics: Adult; Aged; C-Reactive Protein; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glutathione Peroxidase; Humans; Injections, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Sucrose | 2007 |
Intravenous treatment of anaemia with an iron-sucrose preparation.
Topics: Anemia; Anemia, Sickle Cell; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Sucrose | 1949 |
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Drug-Related Side Effects and Adverse Reactions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sucrose | 2009 |
Iron replacement therapy: assessing today's options to prepare for bundling.
Topics: Anemia, Iron-Deficiency; Chemistry, Pharmaceutical; Dextrans; Drug Costs; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Medicare; Reimbursement Mechanisms; Renal Dialysis; Risk Adjustment; Safety; Sucrose; Treatment Outcome; United States | 2010 |
Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival.
Topics: CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; GPI-Linked Proteins; Humans; Iron-Dextran Complex; Lymphocyte Subsets; Molecular Weight; Oxidative Stress; Reactive Oxygen Species; Receptors, IgG; Sucrose | 2010 |
The therapeutic equivalence of complex drugs.
Topics: Anticoagulants; Biological Products; Congresses as Topic; Consumer Product Safety; Drugs, Generic; Evidence-Based Medicine; Ferric Compounds; Ferric Oxide, Saccharated; Glatiramer Acetate; Glucaric Acid; Hematinics; Heparin, Low-Molecular-Weight; Humans; Immunosuppressive Agents; Legislation, Drug; Liposomes; Patents as Topic; Peptides; Proteins; Risk Assessment; Sucrose; Therapeutic Equivalency | 2011 |
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hematinics; Hospital Mortality; Humans; Infusions, Intravenous; Male; Postoperative Period; Preoperative Care; Prospective Studies; Recombinant Proteins; Risk Factors; Spain; Sucrose; Survival Rate; Treatment Outcome | 2012 |
eComment. The problem of anaemia correction in cardiac surgery patients.
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Male; Sucrose | 2012 |
Adverse reaction to intravenous iron: hypersensitivity or secondary side effect?
Topics: Adult; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Sucrose | 2013 |
A case study of an iron-deficient female Olympic 1500-m runner.
Topics: Adolescent; Anemia, Iron-Deficiency; Athletes; Athletic Performance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Lactic Acid; Oxygen Consumption; Running; Sucrose; Young Adult | 2013 |
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
Topics: Anemia, Iron-Deficiency; Chromatography, Gel; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Sucrose | 2014 |
Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria.
Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Protoporphyria, Erythropoietic; Sucrose; Treatment Outcome; Young Adult | 2013 |
Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
Topics: Anemia, Iron-Deficiency; Biological Availability; Cell Culture Techniques; Dose-Response Relationship, Drug; Drug Liberation; Drug Stability; Drugs, Generic; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hep G2 Cells; Humans; Injections, Intravenous; Macrophages; Spectrophotometry, Atomic; Sucrose | 2015 |
Identification of the sentinel node by ultrasonography in patients with breast cancer.
Topics: Adult; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Breast Neoplasms, Male; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Image-Guided Biopsy; Lymph Nodes; Male; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Signal Processing, Computer-Assisted; Sucrose; Technetium; Ultrasonography; Young Adult | 2014 |
Successful treatment with 532-nm Q-switched Nd:YAG laser of cutaneous siderosis following intravenous iron extravasation.
Topics: Aged; Anemia, Iron-Deficiency; Extravasation of Diagnostic and Therapeutic Materials; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Lasers, Solid-State; Male; Skin Diseases; Sucrose | 2015 |
The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fibrinogen; Glucaric Acid; Hemoglobins; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis; ROC Curve; Sucrose | 2013 |
Rapid iron desensitization after generalized urticaria and facial angioedema.
Topics: Anemia, Iron-Deficiency; Angioedema; Desensitization, Immunologic; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Sucrose; Urticaria | 2014 |
Cell viability and chondrogenic differentiation capability of human mesenchymal stem cells after iron labeling with iron sucrose.
Topics: Adolescent; Adult; Aggrecans; Biomarkers; Cell Differentiation; Cell Survival; Cells, Cultured; Chondrocytes; Chondrogenesis; Collagen Type II; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Gene Expression; Glucaric Acid; Humans; Immunohistochemistry; Immunophenotyping; Iron; Mesenchymal Stem Cells; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; SOX9 Transcription Factor; Staining and Labeling; Sucrose; Time Factors; Transforming Growth Factor beta; Young Adult | 2014 |
Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.
Topics: Animals; Apoptosis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Injections, Intradermal; Interleukin-6; Liver; Male; Rats, Sprague-Dawley; Reactive Nitrogen Species; Stress, Physiological; Sucrose; Tumor Necrosis Factor-alpha | 2015 |
Transport of sucrose-modified nanoscale zero-valent iron in saturated porous media: role of media size, injection rate and input concentration.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Groundwater; Iron; Kinetics; Metal Nanoparticles; Porosity; Silicon Dioxide; Sucrose; Suspensions | 2015 |
Biosynthesis of D-glucaric acid from sucrose with routed carbon distribution in metabolically engineered Escherichia coli.
Topics: Escherichia coli; Glucaric Acid; Metabolic Engineering; Microorganisms, Genetically-Modified; Sucrose | 2018 |
Efficient Bioconversion of Sucrose to High-Value-Added Glucaric Acid by In Vitro Metabolic Engineering.
Topics: Biotransformation; Escherichia coli; Glucaric Acid; Metabolic Engineering; Sucrose | 2019 |
Separation of saccharides using fullerene-bonded silica monolithic columns via π interactions in liquid chromatography.
Topics: Chromatography, Liquid; Computer Simulation; Glucaric Acid; Maltose; Mass Spectrometry; Silicon Dioxide; Sucrose; Trehalose | 2020 |